|
KCTD9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.3353997341834E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73490000143772E-10 |
| Normal-vs-Stage2 |
4.808800E-04 |
| Normal-vs-Stage3 |
1.791990E-04 |
| Normal-vs-Stage4 |
5.614700E-04 |
| Stage1-vs-Stage2 |
4.381800E-01 |
| Stage1-vs-Stage3 |
8.803700E-02 |
| Stage1-vs-Stage4 |
3.539800E-02 |
| Stage2-vs-Stage3 |
1.150390E-01 |
| Stage2-vs-Stage4 |
7.953600E-02 |
| Stage3-vs-Stage4 |
7.530000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.82059947515268E-11 |
| Normal-vs-AfricanAmerican |
6.588000E-02 |
| Normal-vs-Asian |
1.514570E-01 |
| Caucasian-vs-AfricanAmerican |
5.68799999999259E-05 |
| Caucasian-vs-Asian |
4.789000E-01 |
| AfricanAmerican-vs-Asian |
5.865200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.41020000916137E-09 |
| Normal-vs-Female |
3.6093000033155E-08 |
| Male-vs-Female |
3.808200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.014200E-02 |
| Normal-vs-Age(41-60Yrs) |
9.93930004966614E-09 |
| Normal-vs-Age(61-80Yrs) |
1.15920000043346E-07 |
| Normal-vs-Age(81-100Yrs) |
1.400010E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.949200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.533400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.186000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.077600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.690000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.359400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.87439999999039E-06 |
| Normal-vs-Grade 2 |
1.89099957914607E-10 |
| Normal-vs-Grade 3 |
1.36239999948273E-07 |
| Normal-vs-Grade 4 |
2.843600E-02 |
| Grade 1-vs-Grade 2 |
4.431600E-01 |
| Grade 1-vs-Grade 3 |
6.416200E-02 |
| Grade 1-vs-Grade 4 |
1.008360E-02 |
| Grade 2-vs-Grade 3 |
1.708170E-02 |
| Grade 2-vs-Grade 4 |
4.001600E-04 |
| Grade 3-vs-Grade 4 |
4.374500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62714286489063E-12 |
| Normal-vs-ccB subtype |
2.284600E-03 |
| ccA subtype-vs-ccB subtype |
2.6015000043067E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.03239999671834E-08 |
| Normal-vs-N1 |
1.133560E-01 |
| N0-vs-N1 |
3.400800E-01 |
|
|
